Analysis of 20 years of data highlights differences in reimbursement trends across ophthalmology subspecialties and practice ...

Abstract: Diabetic retinopathy(DR) has become a major issue among ophthalmologists worldwide, with a majority of type 2 diabetes patients suffering from this disease. Currently, medical diagnosis is ...

Sanofi may rebid for Ocular Therapeutix, Inc. to boost retinal therapeutics ahead of Dupixent patent expiry. Click for more ...

The blood-brain and blood-retinal barriers are protective systems that prevent harmful substances from entering the brain and ...

Given the success of the previous collection, Prevention and Treatment Advancements in Diabetic Retinopathy, we are pleased to announce the launch of Volume ...